LICENSE AGREEMENTS (Details Textual) (USD $)	3 Months Ended		6 Months Ended		15 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2012 LFB Biotechnologies [Member]	Dec. 31, 2011 LFB Biotechnologies [Member]
Stock Issued During Period Shares License Option							132,000
Possible milestone payments to pay upon successful achievement of certain milestones						$ 31,000,000
Bussiness Acquisiton Purchase Agreement Period Description						The license will terminate on a country by country basis upon the expiration of the last licensed patent right or 15 years after the first commercial sale of a product in such country, unless the agreement is earlier terminated.
Sale of Stock, Number of Shares Issued in Transaction						7,368,000
Common Stock Value Subscribed Subsidiary Sale Of Stock						15,000,000
Common Stock Shares Subscribed Subsidiary Sale Of Stock						7,500,000
Noncash stock expense associated with in-licensing agreement	0	297,000	16,578,000	297,000	16,875,000	16,578,000
Subsidiary Shares Conversion Shares To Be Issued						7,500,000
Payments Towards License						$ 0
Noncontrolling Interest, Description						LFB Group owns less than 10% of the outstanding Company Common Stock.